Potent LNA oligonucleotides for the inhibition of HIF-1a expression

Details for Australian Patent Application No. 2005304112 (hide)

Owner Santaris Pharma A/S

Inventors Thrue, Charlotte Albaek; Hansen, Henrik Frydenlund; Rasmussen, Frank Winther; Westergaard, Majken

Agent Cullen & Co

Pub. Number AU-B-2005304112

PCT Pub. Number WO2006/050734

Priority 60/626,563 09.11.04 US; 60/699,721 15.07.05 US; 60/724,621 07.10.05 US; 60/647,186 25.01.05 US

Filing date 9 November 2005

Wipo publication date 18 May 2006

Acceptance publication date 4 June 2009

International Classifications

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

A61K 31/7115 (2006.01) - Nucleic acids or oligonucleotides having modified bases, i.e. other than adenine, guanine, cytosine, uracil or thymine

A61K 31/712 (2006.01) - Nucleic acids or oligonucleotides having modified sugars, i.e. other than ribose or 2'-deoxyribose

A61K 31/7125 (2006.01) - Nucleic acids or oligonucleotides having modified internucleoside linkage, i.e. other than 3'-5' phosphodiesters

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

A61P 17/06 (2006.01) Drugs for dermatological disorders

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

28 June 2007 PCT application entered the National Phase

  PCT publication WO2006/050734 Priority application(s): WO2006/050734

4 June 2009 Application Accepted

  Published as AU-B-2005304112

3 September 2009 Assignment before Grant

  Santaris Pharma A/S The application has been assigned to Santaris Pharma A/S; Enzon Pharmaceuticals, Inc. 2006

1 October 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005304115-Polypeptides having antimicrobial activity and polynucleotides encoding same

2005304110-LNA oligonucleotides and the treatment of cancer